These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 38363545

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Safety of Intravenous Push Lacosamide Compared With Intravenous Piggyback at a Tertiary Academic Medical Center.
    McLaughlin K, Carabetta S, Hunt N, Schuler BR, Ting C, Tran LK, Szumita PM, Anger KE.
    Ann Pharmacother; 2021 Feb; 55(2):181-186. PubMed ID: 32686466
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Safety of Intravenous Push Ertapenem Compared to Intravenous Piggyback at a Tertiary Academic Medical Center.
    Corrado MJ, Riselli A, McLaughlin KC, Szumita PM, Anger KE.
    J Pharm Pract; 2023 Apr; 36(2):281-285. PubMed ID: 34384303
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of Safety Outcomes of Undiluted Levetiracetam Intravenous Push Compared to Intravenous Piggyback.
    Shim A, Radparvar S, Davis N, Kaplan A, Kantaris K, Devlin A, Liang J, Ciummo F.
    J Pharm Pract; 2024 Jun; 37(3):722-727. PubMed ID: 37231709
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of Time to Administration, Benzodiazepine Use, and Safety of Intravenous Push Levetiracetam in a Neuro-Spine Intensive Care Unit.
    Adams T, Greathouse K.
    Neurocrit Care; 2021 Dec; 35(3):789-793. PubMed ID: 34081297
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Safety of Intravenous Olanzapine Administration at a Tertiary Academic Medical Center.
    Hunt NF, McLaughlin KC, Kovacevic MP, Lupi KE, Dube KM.
    Ann Pharmacother; 2021 Sep; 55(9):1127-1133. PubMed ID: 33455436
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Safety Profile of High-Dose Intravenous Push Lacosamide.
    Torian SC, Jones GM.
    Neurohospitalist; 2023 Jul; 13(3):278-282. PubMed ID: 37441206
    [Abstract] [Full Text] [Related]

  • 14. Safety and Efficiency of Intravenous Push Lacosamide Administration.
    Davidson KE, Newell J, Alsherbini K, Krushinski J, Jones GM.
    Neurocrit Care; 2018 Dec; 29(3):491-495. PubMed ID: 29949010
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety of intravenous push thiamine administration at a tertiary academic medical center.
    McLaughlin K, Joyal K, Lee S, Corrado M, Marquis K, Anger K, Szumita P.
    J Am Pharm Assoc (2003); 2020 Dec; 60(4):598-601. PubMed ID: 31932197
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of the Safety of Slow IV Push Versus Slow IV Infusion Administration of 23.4% Sodium Chloride.
    Iskaros O, Arnouk S, Papadopoulos J, Merchan C.
    Neurohospitalist; 2024 Apr; 14(2):122-128. PubMed ID: 38666283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.